Kindred Biosciences to Announce Second Quarter 2020 Financial Results

Kindred Biosciences, Inc. (NASDAQ: KIN) will announce its second quarter 2020 financial results on August 5, 2020, after market close, followed by a conference call at 4:30 p.m. Eastern time.

Rhea-AI Summary

Kindred Biosciences, Inc. (NASDAQ: KIN) will announce its second quarter 2020 financial results on August 5, 2020, after market close, followed by a conference call at 4:30 p.m. Eastern time. Investors can access the call toll-free at (888) 771-4371 or internationally at (847) 585-4405 using conference ID 49852246. The call will also be webcast live, with a replay available for 30 days. Kindred aims to develop innovative biologics for pets, paralleling safe and effective human medicines.

Positive

• Upcoming financial results scheduled for August 5, 2020, which may provide insights into business performance.
• Strong focus on developing innovative therapeutics for pets, indicating growth potential in the pet biopharmaceutical market.

Negative

• None.

Argus Session date unavailable

-0.49% session move Open Argus

Details

News Market Reaction – KIN

The recorded move for KIN in the trading session of this news was -0.49%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN FRANCISCO, July 23, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, will release its second quarter 2020 financial results on August 5, 2020, after the market close. The Company will host a conference call at 4:30 p.m. Eastern time/1:30 p.m. Pacific time that day.

Access the call by dialing toll-free (888) 771-4371 from the U.S. or (847) 585-4405 internationally, and using conference ID 49852246.

The call will also be webcast live here, with a replay available at that link for 30 days.

About Kindred Biosciences
Kindred Biosciences is a biopharmaceutical company developing innovative biologics focused on saving and improving the lives of pets. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy. The company's strategy is to identify targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated targets for dogs and cats. KindredBio has a deep pipeline of novel biologics in development across many therapeutic classes, alongside state-of-the-art biologics manufacturing capabilities and a broad intellectual property portfolio.

For more information, visit: www.kindredbio.com

Contact
Katja Buhrer 
katja.buhrer@kindredbio.com 
(917) 969-3438

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/kindred-biosciences-to-announce-second-quarter-2020-financial-results-301098421.html

SOURCE Kindred Biosciences, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Kindred Biosciences release its Q2 2020 financial results?

Kindred Biosciences will release its Q2 2020 financial results on August 5, 2020.

What time will the conference call for Q2 2020 financial results be held?

The conference call will be held at 4:30 p.m. Eastern time on August 5, 2020.

How can I access the Kindred Biosciences conference call?

You can access the call by dialing toll-free (888) 771-4371 from the U.S. or (847) 585-4405 internationally.

What is the stock symbol for Kindred Biosciences?

The stock symbol for Kindred Biosciences is KIN.

Is there a webcast available for the Kindred Biosciences conference call?

Yes, the conference call will also be webcast live, with a replay available for 30 days.